Nothing Special   »   [go: up one dir, main page]

FI20020360A0 - New use of biologically active product - Google Patents

New use of biologically active product

Info

Publication number
FI20020360A0
FI20020360A0 FI20020360A FI20020360A FI20020360A0 FI 20020360 A0 FI20020360 A0 FI 20020360A0 FI 20020360 A FI20020360 A FI 20020360A FI 20020360 A FI20020360 A FI 20020360A FI 20020360 A0 FI20020360 A0 FI 20020360A0
Authority
FI
Finland
Prior art keywords
biologically active
new use
active product
new
product
Prior art date
Application number
FI20020360A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI112031B (en
Original Assignee
Valio Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valio Oy filed Critical Valio Oy
Priority to FI20020360A priority Critical patent/FI112031B/en
Publication of FI20020360A0 publication Critical patent/FI20020360A0/en
Priority to PCT/FI2002/001051 priority patent/WO2003070267A1/en
Priority to RU2004128448/15A priority patent/RU2004128448A/en
Priority to AU2002352303A priority patent/AU2002352303A1/en
Priority to JP2003569223A priority patent/JP4242293B2/en
Priority to EP02788013A priority patent/EP1485119A1/en
Application granted granted Critical
Publication of FI112031B publication Critical patent/FI112031B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI20020360A 2002-02-25 2002-02-25 New use of a biologically active product FI112031B (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FI20020360A FI112031B (en) 2002-02-25 2002-02-25 New use of a biologically active product
PCT/FI2002/001051 WO2003070267A1 (en) 2002-02-25 2002-12-20 Enhancing the availability of minerals by using biologically active peptides
RU2004128448/15A RU2004128448A (en) 2002-02-25 2002-12-20 INCREASING BIOAVAILABILITY OF MINERALS BY USING BIOLOGICALLY ACTIVE PEPTIDES
AU2002352303A AU2002352303A1 (en) 2002-02-25 2002-12-20 Enhancing the availability of minerals by using biologically active peptides
JP2003569223A JP4242293B2 (en) 2002-02-25 2002-12-20 Composition for increasing bone strengthening and bone formation
EP02788013A EP1485119A1 (en) 2002-02-25 2002-12-20 Enhancing the availability of minerals by using biologically active peptides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20020360A FI112031B (en) 2002-02-25 2002-02-25 New use of a biologically active product
FI20020360 2002-09-02

Publications (2)

Publication Number Publication Date
FI20020360A0 true FI20020360A0 (en) 2002-02-25
FI112031B FI112031B (en) 2003-10-31

Family

ID=8563317

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20020360A FI112031B (en) 2002-02-25 2002-02-25 New use of a biologically active product

Country Status (6)

Country Link
EP (1) EP1485119A1 (en)
JP (1) JP4242293B2 (en)
AU (1) AU2002352303A1 (en)
FI (1) FI112031B (en)
RU (1) RU2004128448A (en)
WO (1) WO2003070267A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4723501B2 (en) * 2004-07-05 2011-07-13 カルピス株式会社 Method for producing peptide mixture, method for producing fermented milk containing antihypertensive peptide and method for producing antihypertensive peptide preparation
PL1820851T3 (en) * 2006-02-20 2012-07-31 Gervais Danone Sa Non-lactose fermenting Lactobacillus helveticus
JP2009537492A (en) * 2006-05-15 2009-10-29 ヴァリオ・リミテッド New uses for therapeutically useful peptides
FI122531B (en) * 2009-09-30 2012-03-15 Valio Oy Cheese and process for making them
WO2012063826A1 (en) * 2010-11-09 2012-05-18 カルピス株式会社 Bacterium lactobacillus helveticus having high proteolysis activity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ183858A (en) * 1976-12-17 1979-10-25 Ashmead Hh Polyvalent metal proteinates as food additives
HUT52962A (en) * 1988-03-04 1990-09-28 Sandoz Ag Process for production of medical compositions eliminating bone-absorption and promoting forming of bones
JP3488722B2 (en) * 1992-03-04 2004-01-19 カルピス株式会社 Calcium absorption promoting activator and method for producing the same
JP2782142B2 (en) 1992-07-23 1998-07-30 カルピス株式会社 Angiotensin converting enzyme inhibitor and method for producing the same
US6214800B1 (en) * 1995-10-25 2001-04-10 Senju Pharmaceutical Co., Ltd. Angiogenesis inhibitor
KR100221124B1 (en) * 1996-09-23 1999-10-01 한상기 Novel casein and preparing method thereof
JP3028411B2 (en) 1997-09-26 2000-04-04 カルピス株式会社 Lactobacillus helveticus lactic acid bacteria with high tripeptide productivity
FI113741B (en) * 1999-11-01 2004-06-15 Valio Oy Process for the preparation of a product containing peptides with antihypertensive effect
WO2001068115A1 (en) * 2000-03-13 2001-09-20 Monsanto Technology Llc Process for producing peptide sequences possessing anti-hypertension activity

Also Published As

Publication number Publication date
FI112031B (en) 2003-10-31
AU2002352303A1 (en) 2003-09-09
RU2004128448A (en) 2005-04-20
JP2005517424A (en) 2005-06-16
EP1485119A1 (en) 2004-12-15
JP4242293B2 (en) 2009-03-25
WO2003070267A1 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
DE60324099D1 (en) DRUG-CONTAINING TAMPON
CY2015015I1 (en) PRODUCTION OF THIACOMYCIN
DE60312780D1 (en) disposable diaper
ATE370714T1 (en) SHAPED TAMPON
IS7571A (en) New physiologically active substances
DE60304102D1 (en) Skin cleansing composition
IS7714A (en) Pharmaceutical formulations of modafinil
NO20044916L (en) Preparations of sulfinylacetamide
DK1572229T3 (en) Stable therapeutic fibrinogen
ATE389742T1 (en) TISSUE TREATMENT PRODUCTS
IS2707B (en) New pharmaceutical formulations of modafinil
NO20043576L (en) Pharmaceutical formulation comprising melatonin
NO20050689L (en) Therapeutic use
FI20020360A0 (en) New use of biologically active product
DE60230292D1 (en) ACTIVE OXYGEN-PRODUCING MATERIAL
ES1052302Y (en) SUPPORT OF MEDICAL SUPPLIES.
EE200300434A (en) Use of pharmaceutically active compounds
IS7902A (en) Anti-skincare composition for skin care
NO20022747L (en) treatment chair
FI20021570A0 (en) Improved structure of coated surgical stent
PT1467737E (en) PHARMACEUTICAL COMPOSITION ORODISPERSIVEL OF PYRIBEDIL
EE200200531A (en) Production and use of therapeutic intracellular antibodies
DE60326437D1 (en) THERAPEUTIC USE OF SAPOGENINES
SE0201783D0 (en) Medical use
DOP2002000452A (en) PCT 2002

Legal Events

Date Code Title Description
MM Patent lapsed